Patents by Inventor John P. Feighner

John P. Feighner has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Therapeutic uses of tri-, tetra-, penta-, and polypeptides
    Publication number: 20080176806
    Abstract: Novel uses of certain peptides to treat patients suffering from neurological or psychiatric disorders are disclosed. The peptides include the tripeptide hormone MIF and compounds made by modifications of MIF, such as modification of amino terminus residues, carboxyl terminus residues and internal residues, including addition and substitution of amino acid residues and modification of the peptide bonds and functional side groups of respective amino acid residues. The tri-, tetra-, penta-, peptides and polypeptides may be utilized alone or in combination with other agents, to treat patients suffering from physiological, psychosomatic, neurological or psychiatric disorders.
    Type: Application
    Filed: July 27, 2004
    Publication date: July 24, 2008
    Inventors: Henry B. Abajian, Joseph J. Hlavka, John P. Feighner
  • Therapeutic uses of tri-, tetra-, penta-, and polypeptides
    Patent number: 6767897
    Abstract: Novel uses of certain peptides to treat patients suffering from neurological or psychiatric disorders are disclosed. The peptides include the tripeptide hormone MIF and compounds made by modifications of MIF, such as modification of amino terminus residues, carboxyl terminus residues and internal residues, including addition and substitution of amino acid residues and modification of the peptide bonds and functional side groups of respective amino acid residues. The tri-, tetra-, penta-, peptides and polypeptides may be utilized alone or in combination with other agents, to treat patients suffering from physiological, psychosomatic, neurological or psychiatric disorders.
    Type: Grant
    Filed: April 11, 2002
    Date of Patent: July 27, 2004
    Assignee: Innapharma, Inc.
    Inventors: Henry B. Abajian, Joseph J. Hlavka, John P. Feighner
  • Therapeutic uses of tri-, tetra-, penta-, and polypeptides
    Publication number: 20030176354
    Abstract: Novel uses of certain peptides to treat patients suffering from neurological or psychiatric disorders are disclosed. The peptides include the tripeptide hormone MIF and compounds made by modifications of MIF, such as modification of amino terminus residues, carboxyl terminus residues and internal residues, including addition and substitution of amino acid residues and modification of the peptide bonds and functional side groups of respective amino acid residues. The tri-, tetra-, penta-, peptides and polypeptides may be utilized alone or in combination with other agents, to treat patients suffering from physiological, psychosomatic, neurological or psychiatric disorders.
    Type: Application
    Filed: April 11, 2002
    Publication date: September 18, 2003
    Inventors: Henry B. Abajian, Joseph J. Hlavka, John P. Feighner